Technologies focused on efficiencies will play a major role in the future of orthopedics, Matthew Harb, MD, said.
The Latest
Pressures related to payers and overhead have made maintaining an orthopedic practice increasingly difficult, says Matthew Harb, MD of The Centers for Advanced Orthopaedics in Washington, D.C.
Here are five spine and orthopedic companies that have recently appointed new presidents and CEOs, as reported by Becker's since Jan. 27:
The global spine biologics market is on pace to have a 17.51% compound annual growth rate from 2024 to 2034, according to a Jan. 31 news release from ResearchandMarkets.com.
Little Rock-based OrthoArkansas has tapped orthopedic surgeon Kirk Reynolds, MD, as its new president.
Mark Bowen, MD, is New York City-based Hospital for Special Surgery's inaugural medical advisor, strategy and business development.
When thinking about the long-term future of spine surgery, some procedures stand out for their cost-effectiveness.
From FDA approvals to medical milestones, here are four key developments from spine and orthopedic medtech companies since Jan. 29.
Tallahassee (Fla.) Orthopedic Clinic has appointed Kelby Tardi as its new CEO following the departure of Michael Boblitz.
Macon-based OrthoGeorgia has earned accreditation from the Accreditation Association for Ambulatory Health Care for total joint replacement and complex spine care.